Quantitative proteomic analysis of ovarian cancer cells identified mitochondrial proteins associated with Paclitaxel resistance.
about
Proteomic Analysis of Anticancer TCMs Targeted at MitochondriaGlycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma.Detection of aggressive prostate cancer associated glycoproteins in urine using glycoproteomics and mass spectrometry.An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors.Mapping tissue-specific expression of extracellular proteins using systematic glycoproteomic analysis of different mouse tissues.Identification, prioritization, and evaluation of glycoproteins for aggressive prostate cancer using quantitative glycoproteomics and antibody-based assays on tissue specimens.Prediction of individual response to anticancer therapy: historical and future perspectivesHuman GM3 Synthase Attenuates Taxol-Triggered Apoptosis Associated with Downregulation of Caspase-3 in Ovarian Cancer Cells.Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics.Proteomic analysis of temporally stimulated ovarian cancer cells for biomarker discoveryAberrant Mucin5B expression in lung adenocarcinomas detected by iTRAQ labeling quantitative proteomics and immunohistochemistry.Proteomics Analysis of Ovarian Cancer Cell Lines and Tissues Reveals Drug Resistance-associated Proteins.Identification of proteins associated with paclitaxel resistance of epithelial ovarian cancer using iTRAQ-based proteomics.Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker Discovery
P2860
Q26777099-DB53787F-5BA6-4662-9A62-935C72FA4D34Q30600084-71D78767-1924-4538-8B16-0CFB7F4F429FQ33609420-C1BA94B2-5247-4A3E-912E-9F50151DDAA3Q33655094-D1EA881D-3B6C-471F-81AA-1CC2A4A0897BQ34336108-3DB6685A-EC91-4678-AFD3-14CBE2A4B865Q34533360-E44457A7-B57E-43F9-ABC5-796C6E165FDEQ35024682-996033FC-B95A-4D98-843C-12C81CB57C36Q35445963-41BCEDD6-8160-449E-82FA-78EF70911AC1Q36184966-1F839E58-1163-49C1-9348-D648D781F9EBQ36596826-E7B5ACF8-968E-4CEA-A1DB-93ACAEB870B6Q37304950-6AC8AB36-E234-4245-ADD3-EFF95BAC34F7Q37607909-E0DBDEB1-D9F3-471F-9B89-F16C4740DB55Q55306983-980E9652-FA73-4EC7-AD7E-95DD3032466BQ57173976-EEC6E81B-5DA2-4937-8F69-BCD29D040FB1
P2860
Quantitative proteomic analysis of ovarian cancer cells identified mitochondrial proteins associated with Paclitaxel resistance.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Quantitative proteomic analysi ...... ed with Paclitaxel resistance.
@ast
Quantitative proteomic analysi ...... ed with Paclitaxel resistance.
@en
Quantitative proteomic analysi ...... ed with Paclitaxel resistance.
@nl
type
label
Quantitative proteomic analysi ...... ed with Paclitaxel resistance.
@ast
Quantitative proteomic analysi ...... ed with Paclitaxel resistance.
@en
Quantitative proteomic analysi ...... ed with Paclitaxel resistance.
@nl
prefLabel
Quantitative proteomic analysi ...... ed with Paclitaxel resistance.
@ast
Quantitative proteomic analysi ...... ed with Paclitaxel resistance.
@en
Quantitative proteomic analysi ...... ed with Paclitaxel resistance.
@nl
P2093
P2860
P356
P1476
Quantitative proteomic analysi ...... ted with Paclitaxel resistance
@en
P2093
Daniel W Chan
Ie-Ming Shih
Matthew T Olson
Natini Jinawath
Zhen Zhang
P2860
P304
P356
10.1002/PRCA.200900005
P577
2009-11-01T00:00:00Z